Skip to content
Screener

Maravai LifeSciences Holdings, Inc. MRVI San Diego Facility Lease — Asset Impairments

Similar metrics at other companies

Andersons Inc. logo
ANDEAgribusiness — Asset impairment
$3.7M
Andersons Inc. logo
ANDERenewables — Asset impairment
$850K
Sun Communities logo
SUIMH / RV — Asset Impairment Charges
$14.1M
Suncoke Energy logo
SXCDomestic Coke — Long-lived asset impairment
$90.1M
El Pollo Loco logo
LOCONV — Impairment Of Long Lived Assets Held For Use
$200K
Ranger Energy Services logo
RNGRReportable Segment — Impairment of assets
$0

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 4:06 PM EST
Fiscal year
FY2025
Accession
0001823239-26-000011

(1) During the fourth quarter of 2025, the Company vacated certain of its facilities in San Diego, California and recorded impairment of long-lived assets totaling $8.3 million ($4.8 million for operating lease right-of-use assets and $3.5 million for property and equipment) within restructuring on the consolidated statements of operations. This reflects the excess of the long-lived assets’ carrying values over their respective fair values, which were determined based on estimated future discounted cash flows and are classified as Level 3 in the fair value hierarchy. As part of the facility reductions, the Company also recorded inventory write-offs of $1.4 million within cost of revenue on the consolidated statements of operations. The Company recorded additional asset impairments totaling $4.9 million ($0.3

Item 8. Financial Statements and Supplementary Data

FAQ

What is Maravai LifeSciences Holdings, Inc.'s san diego facility lease — asset impairments?
Maravai LifeSciences Holdings, Inc. (MRVI) reported san diego facility lease — asset impairments of $8.3M in Q4 2025.
What does san diego facility lease — asset impairments mean?
Represents the total non-cash charges recognized to reduce the carrying value of assets associated with the San Diego facility. This metric reflects potential declines in the utility or market value of physical assets or leasehold interests within this specific geographic location.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s san diego facility lease — asset impairments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude